Case Presentation Schedule
Pharmacotherapeutics II & Clinical Pharmacy II
Date: March 21, 2011
Time: 2:00 pm – 5:00 pm
Venue 1: Lecture Hall Year 3
Time | Group | Case titles |
2:00 – 2:15 pm | B1 | Schizophrenia with multiple bone fractures |
2:16 – 2:30 pm | B3 | Epilepsy |
2:31 – 2:45 pm | C1 | Active TB with dehydration 2⁰ to poor oral intake |
2:46 – 3:00 pm | D3 | PCP |
3:01 – 3:15 pm | E2 | Schizophrenia |
3:16 – 3:30 pm | A1 | Advanced breast cancer |
3:31 – 3:45 pm | C6 | HIV with multiple infections |
3:46 – 4:00 pm | E4 | Seizure |
4:01 – 4:15 pm | A6 | Meningitis |
4:16 – 4:30 pm | A3 | DM with CKD stage 4 |
4:31 – 4:45 pm | D6 | Relapse schizophrenia |
4:46 – 4:00 pm | B2 | Major depressive disorder |
4:01 – 4:15 pm | A5 | Pulmonary tuberculosis |
4:16 – 4:30 pm | C4 | Hospital-acquired pneumonia with septic arthritis |
4:31 – 4:45 pm | D4 | Schizophrenia |
Final comments by evaluators |
Evaluators/Assessors
1. Dr. Zainol Akbar bin Zainal
2. Mdm. Hjh. Rohani bt. Mat Nor
3. Mdm. Siti Halimah Bux bt. Shaikh Rahman Bux
4. Br. Mohd. Hafiz b. Abdul Aziz
Case Presentation Schedule
Pharmacotherapeutics II & Clinical Pharmacy II
Date: March 21, 2011
Time: 2:00 pm – 5:00 pm
Venue 2: Lecture Hall Year 4
Time | Group | Case titles |
2:00 – 2:15 pm | E1 | Relapse schizophrenia |
2:16 – 2:30 pm | B5 | Epilepsy |
2:31 – 2:45 pm | D1 | Hemoptysis 2⁰ to TB |
2:46 – 3:00 pm | C2 | PCP 2⁰ to pulmonary TB |
3:01 – 3:15 pm | E3 | Schizophrenia |
3:16 – 3:30 pm | A2 | Rectosigmoid cancer |
3:31 – 3:45 pm | D5 | TB secondary to HIV infection |
3:46 – 4:00 pm | B4 | Neonatal seizure |
4:01 – 4:15 pm | A4 | Melioidosis |
4:16 – 4:30 pm | D2 | Hypoglycemia 2⁰ to CAP |
4:31 – 4:45 pm | E6 | Relapse schizophrenia |
4:46 – 4:00 pm | B6 | Drug-induced psychosis |
4:01 – 4:15 pm | C3 | Meningococcal tuberculosis |
4:16 – 4:30 pm | C5 | AECOPD 2⁰ to CAP |
4:31 – 4:45 pm | E5 | Schizophrenia |
Final comments by evaluators |
Evaluators/Assessors
1. Dr. Che Suraya bt. Mat Zin
2. Mdm. Nurdiana bt. Jamil
3. Mdm. Nurul Azrin bt Abdul Rahman
4. Dr. Qais Mohammad Ahmad Al-Efan.
No comments:
Post a Comment